We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ALSEN market cap is 184.95M. The company's latest EPS is EUR -0.0735 and P/E is -8.44.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.52M | 2.42M | 4.35M | 5.01M | 5.7M |
| Operating Income | -10.71M | -8.77M | -14.84M | -22.96M | -22.14M |
| Net Income | -12.1M | -8.98M | -15.14M | -23.21M | -22.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 38.1M | 67.9M | 59.09M | 38.95M | 46.5M |
| Total Liabilities | 24.88M | 9.52M | 15.03M | 17.06M | 13.23M |
| Total Equity | 13.22M | 58.38M | 44.06M | 21.89M | 33.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -14.17M | -5.31M | -10.77M | -21.38M | -21.07M |
| Investing | -88k | -165k | -1.08M | -1.54M | -381k |
| Financing | 41.97M | 37.23M | -326k | -844k | 32.2M |
| Market Cap | 184.95M |
| Price to Earnings Ratio | -8.44 |
| Price to Sales Ratio | 32.63 |
| Price to Cash Ratio | 5.04 |
| Price to Book Ratio | 5.59 |
| Dividend Yield | - |
| Shares Outstanding | 300.25M |
| Average Volume (1 week) | 50.63k |
| Average Volume (1 Month) | 39.05k |
| 52 Week Change | 43.42% |
| 52 Week High | 1.04 |
| 52 Week Low | 0.406 |
| Spread (Intraday) | 0.02 (2.6%) |
| Company Name | Sensorion |
| Address |
375 rue du professeur joseph blayac montpellier, herault 34080 |
| Website | https://www.sensorion-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
